[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369623-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369623-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","xenoline-polarized-macrophages-as-an-alternative-in-vitro-model-of-tumor-associated-macrophages-in-glioblastoma","Xenoline-polarized macrophages as an alternative in vitro model of tumor-associated macrophages in glioblastoma","","Tumor-associated macrophages (TAMs) are abundant in glioblastoma (GBM) and shape tumor progression, therapeutic resistance, immune evasion, and neovascularization. Existing IL-4/IL-13-based in vitro models do not reproduce the transcriptional and functional heterogeneity seen in vivo. This study uses a serum-free indirect co-culture with patient-derived xenolines to polarize primary human macrophages and define molecular and functional phenotypes. Xenoline-polarized macrophages diverge from canonical M1/M2 states, reflecting TAM subsets from patients, with distinct interferon/hypoxia or phagocytic signatures.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/xenoline-polarized-macrophages-as-an-alternative-in-vitro-model-of-tumor-associated-macrophages-in-glioblastoma/369623/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/xenoline-polarized-macrophages-as-an-alternative-in-vitro-model-of-tumor-associated-macrophages-in-glioblastoma/369623.png","ImageObject",300,407,{"name":42,"@type":43},"Aditya","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are current IL-4/IL-13 in vitro TAM models insufficient for GBM research?","Question",{"text":63,"@type":64},"They fail to capture the transcriptional and functional heterogeneity of TAMs observed in vivo, limiting how accurately immune interactions are modeled.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the study generate xenoline-polarized macrophages?",{"text":68,"@type":64},"It uses a serum-free indirect co-culture model with patient-derived xenolines to polarize primary human macrophages and then characterizes their molecular and functional phenotypes.",{"name":70,"@type":61,"acceptedAnswer":71},"What key differences were observed between xenoline-polarized macrophages and classical M1/M2 states?",{"text":72,"@type":64},"They do not map to classical M1/M2 transcriptional programs; instead they adopt transcriptional signatures associated with TAM subsets identified from patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369623,1790245787,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Alrefai et al. Acta Neuropathologica Communications (2025) 13:137  \n[https://doi.org/10.1186/s40478-025-02057-1](https://doi.org/10.1186/s40478-025-02057-1)  \nActa Neuropathologica Communications  \nRESEARCH Open Access  \nXenoline-polarized macrophages as an alternative in vitro model of tumor-associated macrophages in glioblastoma  \nHasan Alrefai 1, Benjamin Lin2, Amr Elkholy3, Manoj Kumar 1, Taylor L. Schanel 1, Kevin J. Lee 1, Patricia H. Hicks 1, Joshua C. Anderson 1, Gao Guo4, Eun-Young Erin Ahn3, C. Ryan Miller2 and Christopher D. Willey 1,5*  \nAbstract  \nTumor-associated macrophages (TAMs) are the most abundant non-cancerous cell type in glioblastoma (GBM) and heavily influence GBM biology, contributing to tumor progression, therapeutic resistance, immune evasion, and neovascularization. Current in vitro models that utilize IL-4/IL-13 stimulation fail to capture the transcriptional and functional heterogeneity ofTAMs observed in vivo. In this study, we utilize a serum-free indirect co-culture model with patient-derived xenolines to polarize primary human macrophages and characterize their molecular and functional phenotypes. We demonstrate that xenoline-polarized macrophages diverge from classical M1/ M2 states and instead adopt transcriptional signatures reflective of TAM subsets identified from patients. Notably, macrophages polarized with the radiation-therapy selected xenoline, JX14P-RT, exhibited gene expression patterns enriched for interferon response and hypoxia, mirroring recurrent GBM samples. In contrast, JX14P TAMs showed enrichment in phagocytic gene sets. Functional validation of these phenotypes revealed discrepancies between the transcriptionally predicted and observed phenotypes, emphasizing the importance of integrating phenotypic validation in sequencing studies. Altogether, our findings establish xenoline-polarized macrophages as a useful alternative to traditional models that can be used to study immune-interactions in vitro.  \n*Correspondence: Christopher D. Willey [cwilley@uabmc.edu](cwilley@uabmc.edu)  \n1Department of Radiation Oncology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35233, USA 2Division of Neuropathology, Department of Pathology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35233, USA  \n3Division of Molecular and Cellular Pathology, Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA  \n4Department of Neurosurgery, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35233, USA 5Department of Radiation Oncology, The University of Alabama at Birmingham, HSROC 2220B 619 19th St S, 35249 Birmingham, AL, USA  \nIntroduction  \nGBM is an aggressive and uniformly lethal primary brain tumor with a median survival of 15–18 months, characterized by resistance to traditional therapies [1, 2]. Despite multidisciplinary approaches to treating GBM, including the use of maximally-safe surgical resection, ionizing radiation, temozolomide, Tumor Treating Fields, and various immunomodulatory agents, recurrence is almost inevitable [3–5]. This is largely driven by a subpopulation of cells called brain tumor-initiating cells (BTICs), which exhibit marked resistance to conventional therapies and are thought to repopulate the tumor following treatment [6, 7].  \nBTICs engage, either directly or through other stromal cells, in multiple reciprocal signaling mechanisms  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this l","cbCaifg2EJNl2Aqy","https://ap.wps.com/l/cbCaifg2EJNl2Aqy","pdf",5493196,21,"English","# Abstract\n# Introduction","[{\"question\":\"Why are current IL-4/IL-13 in vitro TAM models insufficient for GBM research?\",\"answer\":\"They fail to capture the transcriptional and functional heterogeneity of TAMs observed in vivo, limiting how accurately immune interactions are modeled.\"},{\"question\":\"How does the study generate xenoline-polarized macrophages?\",\"answer\":\"It uses a serum-free indirect co-culture model with patient-derived xenolines to polarize primary human macrophages and then characterizes their molecular and functional phenotypes.\"},{\"question\":\"What key differences were observed between xenoline-polarized macrophages and classical M1/M2 states?\",\"answer\":\"They do not map to classical M1/M2 transcriptional programs; instead they adopt transcriptional signatures associated with TAM subsets identified from patients.\"}]","Xenoline-polarized macrophages as an alternative in vitro model of tumor-associated macrophages in glioblastoma | PDF",1790183725,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f739440aacf50689c107ff6ad0a92b69.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0604290595cf65bc4b2a2e1c5659a355.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/750b0c8c9051df95c68ed1317ffb4df1.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd27e832545767f93d65108c30103949.webp",980,1306]